e-learning
resources
ERJ
2002
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Mortality in severe sleep apnoea/hypopnoea syndrome patients: impact of treatment
Marti S., Sampol G., Munoz X., Torres F., Roca A., Lloberes P., Sagales T., Quesada P., Morell F.
Source:
Eur Respir J 2002; 20: 1511-1518
Journal Issue:
December
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Marti S., Sampol G., Munoz X., Torres F., Roca A., Lloberes P., Sagales T., Quesada P., Morell F.. Mortality in severe sleep apnoea/hypopnoea syndrome patients: impact of treatment. Eur Respir J 2002; 20: 1511-1518
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Sleep-related breathing disorders: impact on mortality of cerebrovascular disease
Source: Eur Respir J 2004; 24: 267-272
Year: 2004
The prevalance of cardiovascular disorders in patients with obstructive sleep apnoea syndrome
Source: Eur Respir J 2002; 20: Suppl. 38, 293s
Year: 2002
Obstructive sleep apnea syndrome and cardiovascular diseases risk in patients with COPD
Source: Annual Congress 2012 - Physiology, heart failure and respiration in relation to OSA
Year: 2012
The impact of obstructive sleep apnea syndrome on cardiovascular system in children
Source: Annual Congress 2011 - Obstructive sleep apnoea: the heart and the brain
Year: 2011
Cardiovascular risk factors and the metabolic syndrome in patients with obstructive sleep apnea
Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea
Year: 2008
Treatment control in risk patients with obstructive sleep apnea syndrome
Source: Eur Respir J 2006; 28: Suppl. 50, 411s
Year: 2006
Cardiovascular risk, insulin resistance and metabolic syndrome in patients with obstructive sleep apnea
Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea
Year: 2007
Effect of ventilation therapy on mortality rate among obesity hypoventilation syndrome and obstructive sleep apnoea patients
Source: ERJ Open Res, 6 (2) 00101-2019; 10.1183/23120541.00101-2019
Year: 2020
Obstructive sleep apnea syndrome as factor of arrhythmic syndrome emergence and increase of cardiovascular risk in patients with COPD
Source: Annual Congress 2013 –The heart of the matter: sleep disordered breathing
Year: 2013
Mortality in sleep apnoea syndrome: a review of the evidence
Source: Eur Respir Rev 2007; 16: 203-210
Year: 2007
The influence of obesity in patients with obstructive sleep apnea syndrome
Source: Eur Respir J 2002; 20: Suppl. 38, 295s
Year: 2002
Is obstructive sleep apnoea a risk factor for cardiovascular disease?
Source: Annual Congress 2005 - Cardiovascular disease and obstructive sleep apnoea: risks and remedy
Year: 2005
The evaluation of risk of obstructive sleep apnea syndrome in individuals with dysglycaemia
Source: Annual Congress 2012 - Clinical predictors of OSA, adherence to CPAP and psychology
Year: 2012
Cardiovascular, metabolic prognosis and mortality of the positional sleep apnea syndrome: An historical cohort study including 240 patients
Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing
Year: 2013
Cardiovascular morbidity and mortality in patients with obstructive sleep apnea - a prospective study
Source: Annual Congress 2005 - What should we know about our SAS patients
Year: 2005
Prevalence of very severe obstructive sleep apnea syndrome from symptomatic patients.
Source: International Congress 2019 – Screening tools, prevalence and predictors of obstructive sleep apnoea
Year: 2019
Prevalence of metabolic syndrome in patients with hypertension and obstructive sleep apnea
Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea
Year: 2009
Metabolic syndrome in obstructive sleep apnoea patients
Source: Annual Congress 2007 - Sleep apnoea
Year: 2007
High prevalence of sleep apnea syndrome and systemic hypertension at patients with acromegaly
Source: Annual Congress 2010 - The upper airway and oral appliances
Year: 2010
Prevalence of the metabolic syndrome in untreated Mediterranean patients with the obstructive sleep apnea syndrome (OSAS)
Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept